The pharmaceutical industry says it is ready to play its part in meeting the challenge of antimicrobial resistance (AMR) after being buoyed by the UK government's launch of a major proposal that could offer drug makers a new payment model and incentivize more research in the area.
The government has published a 20-year vision and five-year national action plan for how the UK will contribute to containing...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
